Zydus Cadila
-
Coronavirus: Zydus Cadila’s vaccine to be rolled out first in seven states, including UP, Bengal
Scroll Staff
-
India to buy one crore Zydus Cadila’s Covid shot at Rs 265 each
Scroll Staff
-
Zydus Cadila’s two-dose Covid vaccine approved for phase 3 trials by Indian drug regulator
Scroll Staff
-
Coronavirus: Zydus Cadila’s vaccine to be made part of immunisation programme soon, says Centre
Scroll Staff
-
Coronavirus vaccine for children aged 12-17 to be rolled out by October: Covid panel chief
Scroll Staff
-
Coronavirus: India records 30,948 new cases, 10.18% lower than Saturday’s infection count
Scroll Staff
-
Top 10 coronavirus updates: Maharashtra administers record 10.77 lakh vaccines in past 24 hours
Scroll Staff
-
Coronavirus: Zydus Cadila to supply 1 crore vaccine doses by October
Tabassum Barnagarwala
-
Top 10 Covid updates: First vaccine for children aged 12 and above gets clearance in India
Scroll Staff
-
Covid: Zydus Cadila’s vaccine granted emergency use authorisation, first shot for children over 12
Scroll Staff
-
Zydus Cadila seeks emergency use approval for its three-dose Covid vaccine
Scroll Staff
-
Coronavirus: Amid reports of vaccine shortage, finance minister says Centre will take care of states
Scroll Staff
-
Coronavirus: Zydus Cadila vaccine for 12-18 age group will be available soon, Centre tells SC
Scroll Staff
-
Covid-19: Zydus Cadila’s anti-viral drug Virafin gets DCGI approval to treat moderate cases
Scroll Staff
-
Zydus Cadila seeks DCGI approval for using its hepatitis drug for treatment of coronavirus
Scroll Staff
-
Coronavirus: PM Modi to visit three vaccine development plants on Saturday to review work
Scroll Staff
-
Coronavirus: Zydus Cadila launches its remdesivir version in India, priced at Rs 2,800 per vial
Scroll Staff
-
Coronavirus: Maharashtra reports highest one-day rise of 11,514 cases; AP’s tally nears 2 lakh
Scroll Staff
-
Coronavirus: Zydus Cadila is second to begin human trials for potential vaccine in India
Scroll Staff
-
Coronavirus: India’s second vaccine gets approval for two phases of human trials
Scroll Staff